Fig. 1.
Targeted approach to drug development for SARS-CoV-2. The lines of attack against SARS-CoV-2, numbered 1–6, include inhibition of: (1) fusion; (2) translation; (3) proteolysis; (4) translation and RNA replication; (5) packaging and; (6) virion release. From Kupferschmidt and Cohen [3]. With permission